Bill Text: HI HB891 | 2013 | Regular Session | Amended
Bill Title: Workers' Compensation; Drugs
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2013-02-15 - Passed Second Reading as amended in HD 1 and referred to the committee(s) on FIN with none voting aye with reservations; none voting no (0) and Carroll, Coffman, Hanohano, Har, Kawakami, Ward excused (6). [HB891 Detail]
Download: Hawaii-2013-HB891-Amended.html
STAND. COM. REP. NO. 481
Honolulu, Hawaii
, 2013
RE: H.B. No. 891
H.D. 1
Honorable Joseph M. Souki
Speaker, House of Representatives
Twenty-Seventh State Legislature
Regular Session of 2013
State of Hawaii
Sir:
Your Committees on Labor & Public Employment and Health, to which was referred H.B. No. 891 entitled:
"A BILL FOR AN ACT RELATING TO WORKERS' COMPENSATION DRUGS,"
beg leave to report as follows:
Your Committees have amended this measure by:
(1) Providing that the formula for calculating the price for a repackaged or relabeled drug does not apply where the insurance carrier and the specific provider seeking reimbursement have directly contracted between one another for a lower reimbursement amount;
(2) Specifying a formula for calculating the price for a generic drug;
(3) Limiting physician dispensing of repackaged prescription medications to the initial visit only and to a 30-day supply;
(4) Including a two-year sunset provision;
(5) Changing the effective date to July 1, 2113, to promote further discussion; and
(6) Making technical, nonsubstantive amendments for style, clarity, and consistency.
As affirmed by the records of votes of the members of your Committees on Labor & Public Employment and Health that are attached to this report, your Committees are in accord with the intent and purpose of H.B. No. 891, as amended herein, and recommend that it pass Second Reading in the form attached hereto as H.B. No. 891, H.D. 1, and be referred to the Committee on Finance.
Respectfully submitted on behalf of the members of the Committees on Labor & Public Employment and Health,
____________________________ DELLA AU BELATTI, Chair |
|
____________________________ MARK M. NAKASHIMA, Chair |
|
|
|